MSME (Udyam registered) Ministry of MSME
- Category
- Medium (2024-25)
- Udyam number
- UDYAM-DL-01-0013026
Iberia Pharmaceuticals India Limited
Iberia Pharmaceuticals India Limited - trading in New Delhi, Delhi, India. FY 2026 financials & compliance.
Revenue · FY 2023
₹67.39 Cr
▲ 54% YoY
Net profit · FY 2023
₹1.78 Cr
Net margin 2.6%
EBITDA · FY 2023
₹2.52 Cr
EBITDA margin 3.7%
Authorised capital
₹30 Cr
Registered with MCA
Paid-up capital
₹17.66 Lakh
Issued & subscribed
Open charges
₹10.25 Cr
Secured borrowings
Company age
13 yrs
Est. 2013
Employees · EPFO
343
Provident fund records
About Iberia Pharmaceuticals India Limited
Data last updated:
Iberia Pharmaceuticals India Limited is a public limited company based in New Delhi, Delhi, India. It operates in the wholesale trading and distribution segment of the trading and commerce sector. It was incorporated on 30 March 2013 and has been in existence for over 13 years.
The company is registered with the Registrar of Companies (ROC), Delhi, under CIN U24232DL2013PLC250040. Its GSTIN is 07AASCS9462M1ZB (Delhi).
The company has an authorised share capital of ₹30 Cr and a paid-up capital of ₹17.66 Lakh. It was formerly known as Satnam Medical Agencies Private Limited. It is led by directors including Nitin Jain (Managing Director) and Rishab Jain (Whole-Time Director).
Its last annual general meeting (AGM) was held on 30 September 2024, and its latest financial statements are for the year ended 31 March 2024. The registered office is at Property No. 4 Block – C First Floor, Sector – 8 Dwarka, New Delhi, Delhi, India – 110077.
As per the financials filed for FY 2023, the company reported a revenue of ₹67.39 Cr, a growth of 54% compared to the previous year. For the same year it recorded a net profit of ₹1.78 Cr (net margin 2.6%) and EBITDA of ₹2.52 Cr (EBITDA margin 3.7%). Revenue has grown at a compounded annual rate (CAGR) of 45% over three years and 46% over five years.
The company has about 343 employees on its provident fund (EPFO) records.
As per MCA filings, the company has open charges of ₹10.25 Cr on record. Court records list 7 cases involving the company, including 1 filed by the company and 6 filed against it; 2 cases are pending.
Iberia Pharmaceuticals India Limited is registered as a medium enterprise under the Udyam registration framework (Reg. No. UDYAM-DL-01-0013026). The current compliance status is marked as compliant by the Registrar of Companies.
Company details
CIN U24232DL2013PLC250040
Registration Number 250040
Incorporation Date 30 March 2013
ROC Delhi
Listing Status Unlisted
Company Status Active
Compliance Status Active Compliant
MSME Classification Medium
Udyam Registration UDYAM-DL-01-0013026
Name history
Iberia Pharmaceuticals India has undergone 2 name changes throughout its history. The company was previously known as Satnam Medical Agencies Private Limited, and Iberia Pharmaceuticals India Limited. The current legal name is Iberia Pharmaceuticals India Limited.
| Company Name | Status |
|---|---|
| Iberia Pharmaceuticals India Limited | Current |
| Satnam Medical Agencies Private Limited | Previous |
CIN history
Iberia Pharmaceuticals India has one previous CIN (Corporate Identification Number): U24232DL2013PTC250040. The current CIN is U24232DL2013PLC250040, which is the unique identifier assigned by the Registrar of Companies.
| CIN | Status |
|---|---|
| U24232DL2013PLC250040 | Current |
| U24232DL2013PTC250040 | Previous |
Key People
Nitin Jain Managing Director Rishab Jain Whole-Time Director Saurav Ojha Whole-Time Director Recognitions & Rankings of Iberia Pharmaceuticals India
Contact details
Iberia Pharmaceuticals India Limited's registered office is in New Delhi, Delhi. Its e-mail address and telephone number are in the company report.
- Email
- Telephone
- Registered AddressProperty No. 4 Block – C First Floor, Sector – 8 Dwarka, New Delhi, Delhi, India – 110077
- IndustryTrading, Wholesale, Other Wholesale
To see the full contact details of Iberia Pharmaceuticals India Limited, buy the company report.
Comprehensive company report
Iberia Pharmaceuticals India Limited - one report that includes everything
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
₹799 ₹999 20% off excluding 18% GST
Secure checkout · GST invoice included
Business activity
The main business activity of Iberia Pharmaceuticals India is trade. In detail, this covers wholesale trading.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| G | Trade | G1 | Wholesale Trading |
To see the full business activity and turnover split of Iberia Pharmaceuticals India Limited, buy the company report.
Financials of Iberia Pharmaceuticals India Limited
FY 2024 filings availableIberia Pharmaceuticals India Limited reported revenue of ₹67.39 Cr (up 54% YoY) for FY 2023.
Revenue · FY 2023
₹67.39 Cr ▲ 54%
Net profit · FY 2023
₹1.78 Cr margin 2.6%
EBITDA · FY 2023
₹2.52 Cr margin 3.7%
Compounded Annual Growth Rate (CAGR)
Revenue CAGR growth
1 year
▲ 54%
3 years · compounded
▲ 45%
5 years · compounded
▲ 46%
EBITDA CAGR growth
1 year
▲ 341%
3 years · compounded
▲ 174%
5 years · compounded
▲ 93%
Revenue has grown at a compounded annual rate (CAGR) of 46% over five years, including 54% growth in the latest year. EBITDA rose 341% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 | FY 2018-19 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | |||||
| Other Income | |||||
| Total Revenue | ₹67.39 Cr | ||||
| Cost of Materials Consumed | |||||
| Employee Benefit Expense | |||||
| Finance Costs | |||||
| Depreciation and Amortisation | |||||
| Other Expenses | |||||
| Total Expenses | |||||
| EBITDA | ₹2.52 Cr | ||||
| Profit Before Tax | |||||
| Tax Expense | |||||
| Net Profit (PAT) | ₹1.78 Cr | ||||
| Balance Sheet | |||||
| Share Capital | |||||
| Reserves and Surplus | |||||
| Net Worth (Total Equity) | |||||
| Long-term Borrowings | |||||
| Short-term Borrowings | |||||
| Trade Payables | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Metrics | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 | FY 2018-19 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | 3.7% | ||||
| Net Profit Margin | 2.6% | ||||
| Return on Equity (ROE) | |||||
| Return on Capital Employed (ROCE) | |||||
| Return on Assets (ROA) | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Quick Ratio | |||||
| Debt-to-Equity Ratio | |||||
| Interest Coverage Ratio | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Payable Days | |||||
| Inventory Days | |||||
| Revenue Growth | |||||
| Net Profit Growth | |||||
To see the full financial statements and ratios of Iberia Pharmaceuticals India Limited, buy the company report.
Board of directors of Iberia Pharmaceuticals India Limited
Iberia Pharmaceuticals India has 6 current directors and 4 former directors. Current directors are listed first, with their designation and appointment date.
Current Directors
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Rishab Jain | Whole-Time Director | 02 May 2021 | 5 Years 6 Months | Current |
| Nitin Jain | Managing Director | 30 Mar 2013 | 13 Years 7 Months | Current |
| Harmeet Kaur | Director | 01 Mar 2025 | 1 Years 8 Months | Current |
| Atul Bhola Also directs: Gamic Management Services LLP, Magicsapphire Realty LLP, Moonbeam Capital Managers Private Limited and 3 more | Director | 01 Mar 2025 | 1 Years 8 Months | Current |
| Aditya Rungta Also directs: A-Two Group of Hotels LLP, Z-Tech (India) Limited, Markbull Securities Private Limited and 3 more | Director | 01 Mar 2025 | 1 Years 8 Months | Current |
| Saurav Ojha | Whole-Time Director | 30 Sep 2023 | 3 Years 1 Months | Current |
Auditor
Iberia Pharmaceuticals India Limited is audited by KRA & Co. for the financial year 2023.
| Auditor firm | Financial year | Firm registration number |
|---|---|---|
| KRA & Co. | FY 2023 | 020266N |
Shareholding
The shareholding of Iberia Pharmaceuticals India Limited is on record for 5 financial years, the latest being FY 2023, split between promoters, domestic institutions, foreign institutions, public shareholders and others.
| Shareholder category | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 |
|---|---|---|---|---|---|
| Promoters | |||||
| Domestic institutional investors (DII) | |||||
| Foreign institutional investors (FII) | |||||
| Public | |||||
| Others |
To see the full shareholding pattern of Iberia Pharmaceuticals India Limited, buy the company report.
Charges & borrowings
Open charges
₹10.25 Cr
Satisfied charges
None
Breakdown by lending institutions
Latest charge details
| Date | Charge ID | Lender | Amount | Status | Modified or satisfied on |
|---|---|---|---|---|---|
| 27 Dec 2023 | 100850475 | Others | ₹10 Cr | Open | |
| 27 Dec 2023 | 100865259 | Hdfc Bank Limited | ₹25.09 Lakh | Open |
To see the full charge records of Iberia Pharmaceuticals India Limited, buy the company report.
Total charge records: 2 View all charges
Legal cases
Iberia Pharmaceuticals India Limited has 7 court cases on record: 1 filed by Iberia Pharmaceuticals India, 6 filed against it. 2 cases are pending and 5 are disposed.
Total cases
7
Filed by the company
1
Filed against the company
6
Pending
2
Disposed
5
Cases by court
| Court | Cases | Against the company | Pending |
|---|---|---|---|
| District courts | 7 | 6 | 2 |
Cases on record (4 of 7)
| Court | Type of case | Party | Status |
|---|---|---|---|
| District court, Gurugram, Haryana | Civil suit | Filed against the company by Powerup HR Services Pvt Ltd Through Its Authorised Signatory | Pending |
| District court, New Delhi, Delhi | Civil suit | Filed by the company against an individual | Pending |
| District court, South West, Delhi | Civil suit | Filed against the company by State | Disposed |
| District court, West, Delhi | Civil suit | Filed against the company by State | Disposed |
To see the full case history of Iberia Pharmaceuticals India Limited, buy the company report.
Case records are compiled from court listings and may lag the court's own records. A case filed against a company is not a finding against it.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Iberia Pharmaceuticals India Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
Employees & EPFO
Iberia Pharmaceuticals India Limited has a workforce of 343 employees on its EPFO records as of May 2026, across 1 active EPFO establishment.
Employee count
343
Active EPFO establishments
1
Employee growth
15.9%
Headcount by financial year
| Financial year | Employees (EPFO) |
|---|---|
| FY 2026-27 | 343 |
| FY 2025-26 | |
| FY 2024-25 | |
| FY 2023-24 |
To see the full employee and EPFO history of Iberia Pharmaceuticals India Limited, buy the company report.
GST
Iberia Pharmaceuticals India has 1 GST registration: 1 active.
Total GSTINs
1
Active
1
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 07AASCS9462M1ZB | Delhi | Active | 01 Jul 2017 |
To see the full GST registrations and return filing status of Iberia Pharmaceuticals India Limited, buy the company report.
Recent activity
Iberia Pharmaceuticals India Limited has 10 board changes on record since 2013: 6 appointments and 4 cessations. The latest: Aditya Rungta was appointed as Director on 01 Mar 2025.
Charges
A charge with Others of Rs. 10.00 Cr registered on 27 Dec 2023 with Charge ID 100850475 was modified on 06 Aug 2025.
Appointed
Aditya Rungta was appointed as Director.
Appointed
Atul Bhola was appointed as Director.
Appointed
Harmeet Kaur was appointed as Director.
Ceased
Nitin Jain ceased to be Director.
Ceased
Saurav Ojha ceased to be Director.
AGM
Iberia Pharmaceuticals India Limited last Annual general meeting of members was held on 30 Sep 2024 as per latest MCA records.
Filing
Iberia Pharmaceuticals India Limited has filed its annual Financial statements for the year ended 31 Mar 2024 with Roc Delhi.
Charges
A charge with Hdfc Bank Limited amounted to Rs. 0.25 Cr with Charge ID 100865259 was registered on 27 Dec 2023.
Charges
A charge with Others amounted to Rs. 10.00 Cr with Charge ID 100850475 was registered on 27 Dec 2023.
Appointed
Saurav Ojha was appointed as Whole-Time Director.
Ceased
Praveen Jain ceased to be Director.
4 earlier events are in the company report.
Frequently asked questions
Iberia Pharmaceuticals India is an active public limited company based in New Delhi, Delhi, India. The company works in wholesale, within the trading industry. It was incorporated on 30 March 2013 (13+ years old) and is registered under CIN U24232DL2013PLC250040.
Iberia Pharmaceuticals India has 6 current directors:
- Nitin Jain - Managing Director
- Rishab Jain - Whole-Time Director
- Saurav Ojha - Whole-Time Director
- Harmeet Kaur - Director
- Atul Bhola - Director
- Aditya Rungta - Director
The latest financial statements of Iberia Pharmaceuticals India on record with the MCA are for the year ended 31 March 2024. Its last annual general meeting was held on 30 September 2024. Year-wise statements from 2015 are in the company report.
The GSTIN of Iberia Pharmaceuticals India is 07AASCS9462M1ZB, registered in Delhi.
The CIN (Corporate Identification Number) of Iberia Pharmaceuticals India is U24232DL2013PLC250040. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Iberia Pharmaceuticals India has 7 court cases on record: 1 filed by the company and 6 filed against it. 2 are pending.
Iberia Pharmaceuticals India was incorporated on 30 March 2013, making it 13+ years old. It is registered with the Registrar of Companies, Delhi.
Aditya Rungta was appointed as Director on 01 Mar 2025. Atul Bhola was appointed as Director on 01 Mar 2025. Harmeet Kaur was appointed as Director on 01 Mar 2025. Iberia Pharmaceuticals India has 10 board changes on record in total.
Yes, Iberia Pharmaceuticals India is registered as a medium enterprise under Udyam registration (number: UDYAM-DL-01-0013026).
The registered office of Iberia Pharmaceuticals India is at Property No. 4 Block – C First Floor, Sector – 8 Dwarka, New Delhi, Delhi, India – 110077.
Sample company reports
The same report you get when you buy one: financials, directors, ownership, deals, charges, legal cases, brands and filings, with the Excel workbook alongside.
Swiggy Limited Listed company · 92 pages
BharatPe (Resilient Innovations Pvt Ltd) Unlisted company · 78 pages